Ancestral mutations may cause a significant proportion of GCK-MODY

Pediatric Diabetes

Volumn 13, Issue 6, 2012, Pages 489-498

  Dusatkova, Petra ^a   Pruhova, Stepanka ^a   Borowiec, Maciej ^b   Vesela, Klara ^a   Antosik, Karolina ^b   Lebl, Jan ^a   Mlynarski, Wojciech ^b   Cinek, Ondrej ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Founder effect; GCK MODY; Haplotype analysis; Mutation age estimation

Indexed keywords

GLUCOKINASE;

ARTICLE; CZECH REPUBLIC; GENE MUTATION; GENOTYPE; HAPLOTYPE; POPULATION GROWTH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

ADOLESCENT; ADULT; CZECH REPUBLIC; DIABETES MELLITUS, TYPE 2; FAMILY; FEMALE; FOUNDER EFFECT; GENOTYPE; GLUCOKINASE; HUMANS; INHERITANCE PATTERNS; MALE; MUTATION; PEDIGREE; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES; YOUNG ADULT;

EID: 84865647719     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00845.x     Document Type: Article

References (25)

1. Hattersley AT, Turner RC, Permutt MA et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 1992: 339: 1307-1310.
2. Vionnet N, Stoffel M, Takeda J et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992: 356: 721-722.
3. Stenson PD, Mort M, Ball EV et al. The Human Gene Mutation Database: 2008 update. Genome Med 2009: 1: 13.
4. Osbak KK, Colclough K, Saint-Martin C et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat 2009: 30: 1512-1526.
5. Saker PJ, Hattersley AT, Barrow B et al. High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia 1996: 39: 1325-1328.
6. Henderson M, Levy E, Delvin E, Losekoot M, Lambert M. Prevalence and clinical phenotype of the p.Val226Met glucokinase gene mutation in French Canadians in Quebec, Canada. Mol Genet Metab 2007: 90: 87-92.
7. Estalella I, Rica I, Perez de Nanclares G, et al. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol (Oxf) 2007: 67: 538-546.
8. Sagen JV, Bjorkhaug L, Molnes J et al. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry. Pediatr Diabetes 2008: 9: 442-449.
9. Gasperikova D, Tribble ND, Stanik J et al. Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans. Diabetes 2009: 58: 1929-1935.
10. Borowiec M, Antosik K, Fendler W et al. Novel glucokinase mutations in patients with monogenic diabetes - clinical outline of GCK-MD and potential for founder effect in Slavic population. Clin Genet. In press.
11. Pruhova S, Dusatkova P, Sumnik Z et al. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes 2010: 11: 529-535.
12. International HapMap Consortium. The International HapMap Project. Nature 2003: 426: 789-796.
13. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005: 21: 263-265.
14. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001: 68: 978-989.
15. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007: 24: 1596-1599.
16. Sneath PHA, Sokal RR. Numerical Taxonomy. San Francisco, CA: Freeman, 1973.
17. Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 1993: 10: 512-526.
18. Reeve JP, Rannala B. DMLE+: Bayesian linkage disequilibrium gene mapping. Bioinformatics 2002: 18: 894-895.
19. Ledermann HM. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet 1995: 345: 648.
20. Vaxillaire M, Froguel P. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr Rev 2008: 29: 254-264.
21. Aller E, Larrieu L, Jaijo T et al. The USH2A c.2299delG mutation: dating its common origin in a Southern European population. Eur J Hum Genet 2010: 18: 788-793.
22. Cornes BK, Tang CS, Leon TY et al. Haplotype analysis reveals a possible founder effect of RET mutation R114H for Hirschsprung's disease in the Chinese population. PLoS One 2010: 5: e10918.
23. Greenwood CM, Sun S, Veenstra J et al. How old is this mutation? - a study of three Ashkenazi Jewish founder mutations. BMC Genet 2010: 11: 39.
24. Rannala B, Bertorelle G. Using linked markers to infer the age of a mutation. Hum Mutat 2001: 18: 87-100.
25. Vachova Z. K vyvoji slezskych oblasti lidove kultury. Cesky lid 1969: 56: 9-12.